Additional material on the technology can be supplied upon request
[更多]
BBS is a monoclonal antibody that binds specifically and blocks beta-secretase (BACE1) cleavage site on its substrate, APP. BBS inhibits Ab production, a hall-mark of AD and other neurodegenerative diseases such as ALS.The mechanism of action of BBS is based on binding of the antibody at the cell s.....
[更多]
Novel approach for the treatment of Cytomegalovirus (CMV) infection. The technology addresses unmet medical need in the field of CMV management. The use of currently available anti-CMV drugs is limited due to toxicity, low oral bioavailability and drug resistance.We have a pre- clinical proof of co.....
[更多]
| |< <- | [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] | -> >| |
